Multi-modal Exercise Program in Older Adults

Overview

Aim: To evaluate the short-term effects of a multi-modal exercise program on physical performance variables in older adults.

Full Title of Study: “Effects of a Multi-modal Exercise Program in Community-dwelling Older Adults”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Other
    • Masking: Double (Investigator, Outcomes Assessor)
  • Study Primary Completion Date: December 28, 2019

Detailed Description

- Aim: To evaluate the short-term effects of a 16 weeks home-based multi-modal exercise program on physical performance variables in community-dwelling older adults.

- Design: randomized controlled trial.

- Setting: home-based intervention.

Interventions

  • Other: Experimental-Multi-modal exercise program
    • Each home-based session (48) starts with 7 minutes of moderate warm-up exercises focusing on mobility and flexibility. Secondly, the strengthening exercises consist of knee extensions, knee flexions, hip abductions, ankle plantar flexions, and ankle dorsiflexions. Thirdly, a set of balance exercises including knee bends, backwards walking, walking and turning around, sideways walking, tandem stance, tandem walk, one leg stand, heel walking, toe walking, toe to heel walking backwards, sit-to-stand, and stair walking. Finally, participants are instructed to walk at their usual pace for at least 10 minutes.

Arms, Groups and Cohorts

  • Experimental: Experimental-Multi-modal exercise program
    • Each home-based session (48) starts with 7 minutes of moderate warm-up exercises focusing on mobility and flexibility. Secondly, the strengthening exercises consist of knee extensions, knee flexions, hip abductions, ankle plantar flexions, and ankle dorsiflexions. Thirdly, a set of balance exercises including knee bends, backwards walking, walking and turning around, sideways walking, tandem stance, tandem walk, one leg stand, heel walking, toe walking, toe to heel walking backwards, sit-to-stand, and stair walking. Finally, participants are instructed to walk at their usual pace for at least 10 minutes.
  • No Intervention: Control Group
    • No intervention

Clinical Trial Outcome Measures

Primary Measures

  • Timed ‘Up-and-Go’ test (TUG)
    • Time Frame: 16 weeks
    • The participants are instructed to stand up from a standard chair of 45 cm height, walk 3 metre, turn around a cone, return to the chair, and sit down again in the shortest time possible without running. Two trials are performed, and the quicker time in seconds is recorded. Shorter time indicates better performance.

Secondary Measures

  • Repeated chair stand test (STS-5)
    • Time Frame: 16 weeks
    • The participants are instructed to stand from a chair five successive times as quickly as possible without the assistance of their arms. Shorter time indicates better performance.
  • One-Leg Stand test (OLS)
    • Time Frame: 16 weeks
    • Participants are instructed to start the test from a standing position with their eyes open and arms at their sides, choose a leg to stand on, flex the opposite knee, allowing the foot to clear the ground, and stand unassisted on one leg as long as possible. Longer time indicates better performance.

Participating in This Clinical Trial

Inclusion Criteria

  • Age ≥ 65 years
  • Community-dwelling

Exclusion Criteria

  • Unable to ambulate independently
  • Mini-mental state examination score < 24
  • Barthel Index score < 80
  • Unstable cardiovascular disease
  • Neurological disorder that could compromise exercising
  • Upper or lower-extremity fracture in the past year

Gender Eligibility: All

Minimum Age: 65 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Cardenal Herrera University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Juan F. Lisón Párraga, Dr, Head of Medicine – Cardenal Herrera University
  • Overall Official(s)
    • JF Lisón, PhD, Principal Investigator, Cardenal Herrera University
  • Overall Contact(s)
    • JF Lisón, PhD, 96136900064349, juanfran@uchceu.es

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.